Podcast Summary
The landscape of weight loss and obesity care is rapidly evolving, and understanding what's on the horizon can help patients make better informed decisions about their health journey. In this annual predictions episode of the Pound of Cure Weight Loss Podcast, Dr. Matthew Weiner and registered dietitian Zoë review their previous forecasts and share evidence-based predictions for what 2026 will bring in terms of GLP-1 medications, nutrition science, and comprehensive obesity treatment.
The conversation starts with a candid review of their 2025 predictions, examining which forecasts came true and which missed the mark. This honest assessment provides valuable context for understanding how quickly the field of obesity medicine is changing and why staying informed matters for anyone considering or currently using weight loss medications.
One of the most significant topics covered involves the future of GLP-1 medications like semaglutide and tirzepatide. These medications have transformed obesity care over the past few years, but questions remain about accessibility, cost, and long-term use. The podcast team discusses their predictions for medication pricing in 2026, including whether costs will continue to decrease and how that might affect patient access. They also explore expected changes in insurance coverage, which has been a major barrier for many patients seeking these effective treatments.
The episode delves into the ongoing comparison between injectable and oral GLP-1 medications. While injectable forms have dominated the market, oral versions are becoming increasingly available. The discussion covers which format might become more popular in 2026 and what factors patients should consider when choosing between these options. Understanding the practical differences between these delivery methods can help patients work with their healthcare providers to select the approach that best fits their lifestyle and medical needs.
Talk with our team
Have questions about this episode?
Send our Tucson weight loss team a note about bariatric surgery, GLP-1 medications, nutrition, or your next step with Pound of Cure.
More from this episode
A particularly important prediction involves how GLP-1 medications will increasingly be combined with comprehensive nutrition support. The evidence is clear that medications work best when paired with appropriate dietary changes, but the specifics of how to integrate nutrition counseling with medication management continue to evolve. The podcast team shares their thoughts on how this integration will develop over the coming year and what it means for patient outcomes.
The relationship between bariatric surgery and GLP-1 medications also receives attention in this episode. As medications become more effective and accessible, questions arise about how they fit into the broader spectrum of obesity treatment options. The discussion explores whether medications might change the role of bariatric surgery, or whether these tools will increasingly be used in complementary ways to help patients achieve their health goals.
Beyond medications, the episode covers predictions about advances in nutrition science and how our understanding of metabolic health continues to grow. The team discusses emerging research on how different dietary approaches interact with various obesity treatments and what new nutritional strategies might become mainstream in 2026. This information helps patients understand that successful weight management involves more than just medication or surgery but requires attention to overall metabolic health.
The podcast also addresses broader systemic issues in obesity care, including predictions about how medical training might evolve to better prepare physicians to treat obesity as the chronic disease it is. They discuss potential changes in how insurance companies approach coverage decisions and whether policy changes might improve access to comprehensive obesity care.
Throughout the episode, the team emphasizes that their predictions are grounded in current evidence and trends rather than speculation. They draw on their clinical experience in Tucson and nationally to identify patterns that suggest where the field is heading. However, they also acknowledge uncertainty and explain why some predictions are more confident than others.
Patients currently using GLP-1 medications or considering them will find practical insights about what changes they might expect in terms of availability, cost, and how these medications are prescribed. Those who have had bariatric surgery or are considering it will gain perspective on how the surgical approach fits into the evolving treatment landscape.
The episode serves as a valuable resource for anyone interested in staying ahead of developments in obesity medicine. By understanding predicted trends in medication development, insurance coverage, nutrition science, and integrated care models, patients can have more informed conversations with their healthcare providers about their treatment options.
Whether you're just beginning to explore weight loss options or you're already engaged in treatment, this predictions episode offers a roadmap for what's likely coming in obesity care. The insights shared by Dr. Matthew Weiner and his team at Pound of Cure help patients understand not just where obesity treatment is today, but where it's headed tomorrow.
Weight loss topics covered in this episode
This conversation is part of the Pound of Cure approach to evidence-based weight loss education, including bariatric surgery, GLP-1 medications, nutrition counseling, metabolic health, and long-term patient support.
For more context, explore our guides to GLP-1 medications, bariatric surgery in Tucson, and the Metabolic Reset Diet.